Skip to content

NIMH Pages About Alzheimer's Disease

Find current clinical trials on Alzheimer's Disease… 


Science News About Alzheimer's Disease

Suppressing Protein May Stem Alzheimer’s Disease Process

Press Release

CD33 activity and beta-amyloid

Scientists funded by the National Institutes of Health have discovered a potential strategy for developing treatments to stem the disease process in Alzheimer’s disease, by blocking activity of a little-known regulator protein called CD33.

Continue Reading…

Mental Decline Thwarted in Aging Rats

Press Release

P7C3 compound chemical structure

Scientists have discovered a compound that restores the capacity to form new memories in aging rats, likely by improving the survival of newborn neurons in the brain's memory hub. The research, funded in part by the National Institutes of Health, has turned up clues to a neuroprotective mechanism that could lead to a treatment for Alzheimer's disease.

Continue Reading…

Use of Antipsychotics in Alzheimer’s Patients May Lead to Detrimental Metabolic Changes

Science Update

Woman looking out a window (photograph).

Atypical antipsychotic medications are associated with weight gain and other metabolic changes among patients with Alzheimer’s disease, according to a recent analysis of data from the NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness—Alzheimer’s Disease (CATIE-AD) study. The study was published online ahead of print April 15, 2009, in the American Journal of Psychiatry.

Continue Reading…

Antipsychotic Medications May Ease Some Alzheimer’s Symptoms, Not Others

Science Update

Antipsychotic medications may lessen symptoms like hostility and aggression in patients with Alzheimer’s disease, but do not appear to lessen other symptoms or improve quality of life, according to a recent analysis of data from the NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer’s Disease (CATIE-AD) study.

Continue Reading…

Cortex Area Thinner in Youth with Alzheimer’s-Related Gene

Press Release

A part of the brain first affected by Alzheimer’s disease is thinner in youth with a risk gene for the disorder, a brain imaging study by researchers at the National Institute of Mental Health (NIMH), one of the National Institutes of Health (NIH), has found.

Continue Reading…


Director’s Updates About Alzheimer's Disease

NIMH Perspective on Treating Alzheimer’s Patients with Antipsychotic Medications

The recent publication of phase 1 results from the NIMH-funded Clinical Antipsychotic Trials in Intervention Effectiveness for Alzheimer's disease (CATIE-AD) in the New England Journal of Medicine provides new information about the use of several "atypical" antipsychotic medications for the treatment of psychotic symptoms in patients with Alzheimer's disease.

Continue Reading…

NIMH Topics

Disorders

Populations

Research

Other